REPORT ID 230

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2019-2025

Publish Date
2019
Pages
126
Format
Electronic (PDF)

The Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast  2019-2025 is a valuable source of insightful data for business strategists. It provides the Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Non-alcoholic Fatty Liver Disease (NAFLD) Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
...

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Product Segment Analysis
Type 1
Type 2
Type 3 
 

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Application Segment Analysis
Application 1
Application 2
Application 3 

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments  
			   
Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast  2019-2025

Chapter 1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Type
1.2.1 Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Application
1.3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
1.3.2 Application 1 
1.3.3 Application 2
1.3.4 Application 3
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug ( 2014-2024)

Chapter 2 Global Economic Impact on Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Share by Manufacturers (2015 and 2016)
3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competitive Situation and Trends
3.5.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Concentration Rate
3.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue (Value) by Region ( 2014-2019)
4.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Region ( 2014-2019)
4.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Market Share by Region ( 2014-2019)
4.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Value) and Market Share by Region ( 2014-2019)
4.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)
4.5 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)
4.6 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)
4.7 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)
4.8 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)
4.9 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)
4.10 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin ( 2014-2019)

Chapter 5 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Supply (Production), Consumption, Export, Import by Regions ( 2014-2019)
5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Regions ( 2014-2019)
5.2 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions ( 2014-2019)
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions ( 2014-2019)
5.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions ( 2014-2019)
5.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions ( 2014-2019)
5.6 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions ( 2014-2019)
5.7 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions ( 2014-2019)

Chapter 6 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue (Value), Price Trend by Type
6.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Type ( 2014-2019)
6.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type ( 2014-2019)
6.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type ( 2014-2019)
6.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type ( 2014-2019)

Chapter 7 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Application
7.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption and Market Share by Application ( 2014-2019)
7.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application ( 2014-2019)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
8.1 Conatus Pharmaceuticals
8.1.1 Company Basic Information, Manufacturing Base and Competitors
8.1.2 Product Type, Application and Specification
8.1.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.1.4 Business Overview
8.2 Daewoong Pharmaceutical
8.2.1 Company Basic Information, Manufacturing Base and Competitors
8.2.2 Product Type, Application and Specification
8.2.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.2.4 Business Overview
8.3 Galmed International
8.3.1 Company Basic Information, Manufacturing Base and Competitors
8.3.2 Product Type, Application and Specification
8.3.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.3.4 Business Overview
8.4 Kyorin Pharmaceutical
8.4.1 Company Basic Information, Manufacturing Base and Competitors
8.4.2 Product Type, Application and Specification
8.4.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.4.4 Business Overview
8.5 Metabolic Solutions Development
8.5.1 Company Basic Information, Manufacturing Base and Competitors
8.5.2 Product Type, Application and Specification
8.5.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.5.4 Business Overview
8.6 Novartis AG
8.6.1 Company Basic Information, Manufacturing Base and Competitors
8.6.2 Product Type, Application and Specification
8.6.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.6.4 Business Overview
8.7 Phenex Pharmaceuticals
8.7.1 Company Basic Information, Manufacturing Base and Competitors
8.7.2 Product Type, Application and Specification
8.7.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.7.4 Business Overview
8.8 Raptor Pharmaceuticals
8.8.1 Company Basic Information, Manufacturing Base and Competitors
8.8.2 Product Type, Application and Specification
8.8.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.8.4 Business Overview
8.9 TCM Biotech International
8.9.1 Company Basic Information, Manufacturing Base and Competitors
8.9.2 Product Type, Application and Specification
8.9.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
8.9.4 Business Overview
?

Chapter 9 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis
9.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Price Trend of Key Raw Materials
9.1.3 Key Suppliers of Raw Materials
9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.2.1 Raw Materials
9.2.2 Labor Cost
9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers
10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
10.4 Downstream Buyers

Chapter 11 Marketing Strategy Analysis, Distributors/Traders
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors/Traders List

Chapter 12 Market Effect Factors Analysis
12.1 Technology Progress/Risk
12.1.1 Substitutes Threat
12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

Chapter 13 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast ( 2019-2025)
13.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue Forecast ( 2019-2025)
13.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption Forecast by Regions ( 2019-2025)
13.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type ( 2019-2025)
13.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application ( 2019-2025)
13.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Forecast ( 2019-2025)

Chapter 14 Appendix